Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical corporation that specializes in the discovery, development, manufacturing, and distribution of medicines. Its portfolio spans various therapeutic areas, including neuroscience, cardiometabolic, cancer, and immunology. Notable products include Verzenio for cancer, Mounjaro and Jardiance for cardiometabolic conditions, and Taltz for immunology. The company operates through owned or leased facilities in over 25 countries, selling its products in approximately 135 countries worldwide. Additionally, Eli Lilly and Company Foundation, established in 1968, supports initiatives aimed at improving patient outcomes, enhancing quality of life, and promoting education, particularly in underserved communities.

Andrew Adams

Group Vice President - Molecule Discovery and Director, Lilly Institutes of Genetic Medicine

Anat Ashkenazi

CFO

Gordon Brooks

Group Vice President - Controller and Corporate Strategy

Lotus Mallbris Ph.D

Vice President of Development and Immunology

Teresa Millan

Corporate Affairs Director

Jacob Van Naarden

President

Diogo Rau

Executive Vice President and Chief Information and Digital Officer

Melissa Seymour

Executive VP of Global Quality

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.